Reactive oxygen species scavenging nanomedicine for the treatment of ischemic heart disease
Ischemic heart disease (IHD) is the leading cause of disability and mortality worldwide.
Reactive oxygen species (ROS) have been shown to play key roles in the progression of …
Reactive oxygen species (ROS) have been shown to play key roles in the progression of …
The vascular endothelium and coagulation: homeostasis, disease, and treatment, with a focus on the von willebrand factor and factors VIII and V
JAD Pablo-Moreno, LJ Serrano, L Revuelta… - International Journal of …, 2022 - mdpi.com
The vascular endothelium has several important functions, including hemostasis. The
homeostasis of hemostasis is based on a fine balance between procoagulant and …
homeostasis of hemostasis is based on a fine balance between procoagulant and …
Breaking through the basement membrane barrier to improve nanotherapeutic delivery to tumours
Q Wang, Q Liang, J Dou, H Zhou, C Zeng, H Pan… - Nature …, 2024 - nature.com
An effective nanotherapeutic transport from the vasculature to the tumour is crucial for
cancer treatment with minimal side effects. Here we demonstrate that, in addition to the …
cancer treatment with minimal side effects. Here we demonstrate that, in addition to the …
Flash drug release from nanoparticles accumulated in the targeted blood vessels facilitates the tumour treatment
Tumour microenvironment hinders nanoparticle transport deep into the tissue precluding
thorough treatment of solid tumours and metastatic nodes. We introduce an anticancer drug …
thorough treatment of solid tumours and metastatic nodes. We introduce an anticancer drug …
Organ-specific endothelial cell differentiation and impact of microenvironmental cues on endothelial heterogeneity
L Gifre-Renom, M Daems, A Luttun… - International journal of …, 2022 - mdpi.com
Endothelial cells throughout the body are heterogeneous, and this is tightly linked to the
specific functions of organs and tissues. Heterogeneity is already determined from …
specific functions of organs and tissues. Heterogeneity is already determined from …
Dual affinity to RBCs and target cells (DART) enhances both organ-and cell type-targeting of intravascular nanocarriers
LT Ferguson, ED Hood, T Shuvaeva, VV Shuvaev… - ACS …, 2022 - ACS Publications
A long-standing goal of nanomedicine is to improve a drug's benefit by loading it into a
nanocarrier that homes solely to a specific target cell and organ. Unfortunately, nanocarriers …
nanocarrier that homes solely to a specific target cell and organ. Unfortunately, nanocarriers …
Lipid nanoparticles for nucleic acid delivery to endothelial cells
GW Liu, EB Guzman, N Menon, RS Langer - Pharmaceutical Research, 2023 - Springer
Endothelial cells play critical roles in circulatory homeostasis and are also the gateway to
the major organs of the body. Dysfunction, injury, and gene expression profiles of these cells …
the major organs of the body. Dysfunction, injury, and gene expression profiles of these cells …
Lysosomal nanotoxicity: Impact of nanomedicines on lysosomal function
Although several nanomedicines got clinical approval over the past two decades, the clinical
translation rate is relatively small so far. There are many post-surveillance withdrawals of …
translation rate is relatively small so far. There are many post-surveillance withdrawals of …
[HTML][HTML] Fluorinated amphiphilic Poly (β-Amino ester) nanoparticle for highly efficient and specific delivery of nucleic acids to the Lung capillary endothelium
Endothelial cell dysfunction occurs in a variety of acute and chronic pulmonary diseases
including pulmonary hypertension, viral and bacterial pneumonia, bronchopulmonary …
including pulmonary hypertension, viral and bacterial pneumonia, bronchopulmonary …
Advances in the treatment of atherosclerosis with ligand‐modified nanocarriers
X Deng, J Wang, S Yu, S Tan, T Yu, Q Xu, N Chen… - …, 2024 - Wiley Online Library
Atherosclerosis, a chronic disease associated with metabolism, poses a significant risk to
human well‐being. Currently, existing treatments for atherosclerosis lack sufficient efficiency …
human well‐being. Currently, existing treatments for atherosclerosis lack sufficient efficiency …